Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply

N Engl J Med. 2021 Jan 7;384(1):84-85. doi: 10.1056/NEJMc2032399.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Child
  • Humans
  • Hyperlipoproteinemia Type II* / drug therapy
  • Hyperlipoproteinemia Type II* / genetics

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • evolocumab